The clinical trial of the personalized vaccine NeoVax(MI) has shown promising results in the treatment of melanoma, generating a strong immune response. The vaccine contains patient-specific neoantigens and is administered together with standard immunotherapies such as nivolumab and ipilimumab. Scientists observed an increase in immune cells after vaccination, indicating effective immune activation. This innovative approach could significantly improve treatments for skin cancer.
Sources
Vaccinul contra unui tip agresiv de cancer, la un pas de a intra pe piață. Rezultatele remarcabile dau speranțe pacienților
Consiliul Concurenței analizează tranzacţia prin care Mehiläinen Oy preia rețeaua de centre mediale Regina Maria
Consiliul Concurenţei analizează preluarea Grupului Regina Maria de către Mehiläinen Oy
Latest News
22:43
A delivery driver from Sri Lanka attacked in Iași County. The attacker destroyed his scooter and phone
22:27
Ilie Bolojan, on the risk of the PNL splitting: “We do not expect anyone to leave the party”
22:04
Donald Trump announces good talks with Vladimir Putin and says that the Russian leader wants to end the war in Ukraine through diplomatic means
21:51
Zohran Mamdani announces the closure of the Rikers Island prison complex by 2032
21:21
EUROCONTROL blocks the sums owed to ROMATSA again / The garnishment was imposed at Pfizer’s request in the dispute concerning COVID-19 vaccines
See more news